A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

Hortobagyi, 1988, Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy, Cancer, 62, 2507, 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D

Jacquillat, 1990, Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer, Cancer, 66, 119, 10.1002/1097-0142(19900701)66:1<119::AID-CNCR2820660122>3.0.CO;2-3

Fisher, 1989, Presence of a growth stimulating factor in serum following primary tumor removal in mice, Cancer Res, 49, 1996

Fisher, 1989, Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth stimulating factor in mice, Cancer Res, 49, 2002

Goldie, 1979, A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate, Cancer Treat Rep, 63, 1727

Powles, 1995, Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer, J Clin Oncol, 13, 547, 10.1200/JCO.1995.13.3.547

Hayward, 1977, Assessment of response to therapy in advanced breast cancer, Br J Cancer, 35, 292, 10.1038/bjc.1977.42

Montes, 1993, A toxic interaction between mitomycin-C and tamoxifen causing the haemolytic uraemic syndrome, Eur J Cancer, 29A, 1854, 10.1016/0959-8049(93)90537-P

Mansi, 1989, Primary medical treatment for operable breast cancer, Eur J Clin Oncol, 25, 1623, 10.1016/0277-5379(89)90308-8

Smith, 1993, Primary medical (neoadjuvant) chemotherapy for operable breast cancer, Eur J Cancer, 29A, 1796, 10.1016/0959-8049(93)90133-Z

Bonadonna, 1990, Primary chemotherapy to avoid mastectomy in tumors with diameter of three centimeters or more, J Natl Cancer Inst, 82, 1539, 10.1093/jnci/82.19.1539

Scholl, 1994, Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6, Eur J Cancer, 30A, 645, 10.1016/0959-8049(94)90537-1

Mauriac, 1991, Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre, Ann Oncol, 2, 347, 10.1093/oxfordjournals.annonc.a057953

Fisher, 1997, Effect of preoperative therapy for primary breast cancer (BC) on local-regional disease, disease-free survival (DFS) and survival (S): Results from NSABP B-18, Proc Annu Meet Am Soc Clin Oncol, 16, 127

Scholl, 1996, Breast tumour response to primary chemotherapy predicts local and distant control as well as survival, Eur J Cancer, 31A, 1969, 10.1016/0959-8049(95)00454-8

1992, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. One hundred thirty-three randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women, Lancet, 339, 1

Pierquin, 1980, Radical radiation therapy of breast cancer, Int J Radiat Oncol Biol Phys, 6, 17, 10.1016/0360-3016(80)90197-2

Amalric, 1982, Radiation therapy with or without primary limited surgery for operable breast cancer: A 20-year experience at the Marsaille Cancer Institute, Cancer, 49, 30, 10.1002/1097-0142(19820101)49:1<30::AID-CNCR2820490107>3.0.CO;2-L

Van Limbergen, 1990, Local control of operable breast cancer after radiotherapy alone, Eur J Cancer, 26, 674, 10.1016/0277-5379(90)90115-A